Montelukast study for breathing problems in premature infants
Treatments studied
Part of Genetic & congenital, Lungs & breathing, Women’s health & pregnancy clinical trials.
This trial tests if the medicine montelukast can help very premature babies on breathing machines. It aims to see if it improves lung development and makes it easier for them to breathe on their own.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Baby is on a breathing machine (ventilator) and needs extra oxygen
- Born before 28 weeks of pregnancy and weighed less than 2.2 pounds at birth
- Baby is 7 to 28 days old when starting the study medicine
- Parents or guardians have agreed in writing (informed consent)
- Baby can handle small feedings (5 mL) through a tube into the stomach
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a careful CPAP breathing support plan helps very premature babies breathe better. It may be an option for babies who are stable on low oxygen settings and have few breathing pauses.
This study tests whether a steroid medicine called dexamethasone can help prevent a serious lung problem in very premature babies who need a breathing machine for a long time. It may help babies who are still on the machine after two weeks and need high levels of oxygen.
This trial tests whether a type of stem cell (mesenchymal stromal cells) can help prevent bronchopulmonary dysplasia, a serious lung condition, in very premature babies. Babies born before 28 weeks who are on a breathing machine with high oxygen needs may be eligible.
This study tests a new medicine called APC-0101, a type of surfactant, for premature babies with breathing problems (respiratory distress syndrome). It may help their lungs work better and reduce the need for more breathing support.
This study tests whether montelukast, a medicine that helps reduce airway inflammation, can improve symptoms of acute bronchiolitis (a common lung infection in babies) when given early. It may help babies breathe easier and recover faster.
This trial tests a new treatment to help very premature babies (born at 22 to nearly 29 weeks) who still need a breathing machine and extra oxygen at 1–2 weeks old. The goal is to see if it can improve their lung health and reduce the need for breathing support.
Hear when a new Bronchopulmonary Dysplasia (BPD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.